Copyright © 2012 Jenny Amaya-Amaya et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. D. L. Scott, F. Wolfe, and T. W. J. Huizinga, “Rheumatoid arthritis,” The Lancet, vol. 376, no. 9746, pp. 1094–1108, 2010. View at Publisher · View at Google Scholar · View at Scopus
2. P. L. C. M. van Riel and J. Fransen, “Established rheumatoid arthritis: clinical assessments,” Best Practice and Research: Clinical Rheumatology, vol. 21, no. 5, pp. 807–825, 2007. View at Publisher · View at Google Scholar · View at Scopus
3. J. A. Rindfleisch and D. Muller, “Diagnosis and management of rheumatoid arthritis,” American Family Physician, vol. 72, no. 6, pp. 1037–1047, 2005. View at Scopus
4. J. M. Anaya, “Severe rheumatoid valvular heart disease,” Clinical Rheumatology, vol. 25, no. 5, pp. 743–745, 2006. View at Publisher · View at Google Scholar · View at Scopus
5. A. N. DeMaria, “Relative risk of cardiovascular events in patients with rheumatoid arthritis,” American Journal of Cardiology, vol. 89, no. 6, pp. 33D–38D, 2002. View at Scopus
6. T. Sokka, E. Krishnan, A. Häkkinen, and P. Hannonen, “Functional disability in rheumatoid arthritis patients compared with a community population in Finland,” Arthritis and Rheumatism, vol. 48, no. 1, pp. 59–63, 2003. View at Publisher · View at Google Scholar · View at Scopus
7. F. Wolfe, “A reappraisal of HAQ disability in rheumatoid arthritis,” Arthritis and Rheumatism, vol. 43, pp. 2751–2761, 2000.
8. J. Cadena, S. Vinaccia, A. Pérez, M. I. Rico, R. Hinojosa, and J. M. Anaya, “The impact of disease activity on the quality of life, mental health status, and family dysfunction in colombian patients with rheumatoid arthritis,” Journal of Clinical Rheumatology, vol. 9, no. 3, pp. 142–150, 2003. View at Publisher · View at Google Scholar · View at Scopus
9. A. Rojas-Villarraga, J. Bayona, N. Zuluaga, S. Mejia, M. E. Hincapie, and J. M. Anaya, “The impact of rheumatoid foot on disability in Colombian patients with rheumatoid arthritis,” BMC Musculoskeletal Disorders, vol. 10, no. 1, article 67, 2009. View at Publisher · View at Google Scholar · View at Scopus
10. A. Sandoo, D. Carroll, G. S. Metsios, G. D. Kitas, and J. J. C. S. Veldhuijzen van Zanten, “The association between microvascular and macrovascular endothelial function in patients with rheumatoid arthritis: a cross-sectional study,” Arthritis Research and Therapy, vol. 13, no. 3, article R99, 2011. View at Publisher · View at Google Scholar · View at Scopus
11. M. J. L. Peters, D. P. M. Symmons, D. McCarey et al., “EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis,” Annals of the Rheumatic Diseases, vol. 69, no. 2, pp. 325–331, 2010. View at Publisher · View at Google Scholar · View at Scopus
12. Y. Alamanos and A. A. Drosos, “Epidemiology of adult rheumatoid arthritis,” Autoimmunity Reviews, vol. 4, no. 3, pp. 130–136, 2005. View at Publisher · View at Google Scholar · View at Scopus
13. T. K. Kvien, T. Uhlig, S. Ødegård, and M. S. Heiberg, “Epidemiological aspects of rheumatoid arthritis: the sex ratio,” Annals of the New York Academy of Sciences, vol. 1069, pp. 212–222, 2006. View at Publisher · View at Google Scholar · View at Scopus
14. S. E. Gabriel, C. S. Crowson, H. M. Kremers et al., “Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years,” Arthritis and Rheumatism, vol. 48, no. 1, pp. 54–58, 2003. View at Publisher · View at Google Scholar · View at Scopus
15. D. Symmons, G. Turner, R. Webb et al., “The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century,” Rheumatology, vol. 41, no. 7, pp. 793–800, 2002. View at Scopus
16. A. M. Delgado-Vega and J. M. Anaya, “Meta-analysis of HLA-DRB1 polymorphism in Latin American patients with rheumatoid arthritis,” Autoimmunity Reviews, vol. 6, no. 6, pp. 402–408, 2007. View at Publisher · View at Google Scholar · View at Scopus
17. B. F. Leeb, J. Sautner, H. T. H. Mai, P. M. Haindl, C. Deutsch, and B. Rintelen, “A comparison of patient questionnaires and composite indexes in routine care of rheumatoid arthritis patients,” Joint Bone Spine, vol. 76, no. 6, pp. 658–664, 2009. View at Publisher · View at Google Scholar · View at Scopus
18. T. Pincus, “Pain, function, and RAPID scores: vital signs in chronic diseases, analogous to pulse and temperature in acute diseases and blood pressure and cholesterol in long-term health,” Bulletin of the NYU Hospital for Joint Diseases, vol. 66, no. 2, pp. 155–165, 2008. View at Scopus
19. T. Pincus and T. Sokka, “Quantitative clinical assessment in busy rheumatology settings: the value of short patient questionnaires,” Journal of Rheumatology, vol. 35, no. 7, pp. 1235–1237, 2008. View at Scopus
20. T. Pincus, Y. Yazici, and M. J. Bergman, “Patient questionnaires in rheumatoid arthritis: advantages and limitations as quantitative, standardized scientific medical history,” Rheumatic Disease Clinics of North America, vol. 35, no. 4, pp. 735–743, 2009. View at Publisher · View at Google Scholar · View at Scopus
21. T. Pincus and C. J. Swearingen, “The HAQ compared with the MDHAQ: " keep it simple, stupid" (KISS), with feasibility and clinical value as primary criteria for patient questionnaires in usual clinical care,” Rheumatic Disease Clinics of North America, vol. 35, no. 4, pp. 787–798, 2009. View at Publisher · View at Google Scholar · View at Scopus
22. F. Salaffi, A. Stancati, R. Neri, W. Grassi, and S. Bombardieri, “Measuring functional disability in early rheumatoid arthritis: the validity, reliability and responsiveness of the Recent-Onset Arthritis Disability (ROAD) index,” Clinical and Experimental Rheumatology, vol. 23, no. 5, pp. S31–S42, 2005. View at Scopus
23. C. G. Schneeberger EE, M. F. Marengo, S. B. Papasidero, and R. E. Chaparro-del Moral, “Clinimetria en artritis reumatoidea,” Revista Argentina de Reumatología, vol. 2, 2008.
24. T. Pincus, “Are patient questionnaire scores as "scientific" as laboratory tests for rheumatology clinical care?” Bulletin of the NYU Hospital for Joint Diseases, vol. 68, no. 2, pp. 130–139, 2010. View at Scopus
25. C. V. Caballero-Uribe, “Artritis reumatoide como enfermedad de alto costo,” Revista Colombiana de Reumatología, vol. 11, pp. 225–231, 2004.
26. K. E. Lasch, P. Marquis, M. Vigneux et al., “PRO development: rigorous qualitative research as the crucial foundation,” Quality of Life Research, vol. 19, no. 8, pp. 1087–1096, 2010. View at Publisher · View at Google Scholar · View at Scopus
27. B. Bruce and J. F. Fries, “The Health Assessment Questionnaire (HAQ),” Clinical and Experimental Rheumatology, vol. 23, pp. S14–S18, 2005. View at Scopus
28. R. Seror, F. Tubach, G. Baron, F. Guillemin, and P. Ravaud, “Measure of function in rheumatoid arthritis: individualised or classical scales?” Annals of the Rheumatic Diseases, vol. 69, no. 1, pp. 97–101, 2010. View at Publisher · View at Google Scholar · View at Scopus
29. M. Her and A. Kavanaugh, “Patient-reported outcomes in rheumatoid arthritis,” Current Opinion in Rheumatology, vol. 24, pp. 327–334, 2012. View at Publisher · View at Google Scholar
30. G. Stucki, M. H. Liang, S. Stucki, P. Brühlmann, and B. A. Michel, “A self-administered Rheumatoid Arthritis Disease Activity Index (RADAI) for epidemiologic research: psychometric properties and correlation with parameters of disease activity,” Arthritis and Rheumatism, vol. 38, no. 6, pp. 795–798, 1995. View at Publisher · View at Google Scholar · View at Scopus
31. T. Li, G. Wells, R. Westhovens, and P. Tugwell, “Validation of a simple activity participation measure for rheumatoid arthritis clinical trials,” Rheumatology, vol. 48, no. 2, pp. 170–175, 2009. View at Publisher · View at Google Scholar · View at Scopus
32. F. Wolfe, K. Michaud, and T. Pincus, “Development and validation of the Health Assessment Questionnaire II: a revised version of the Health Assessment Questionnaire,” Arthritis and Rheumatism, vol. 50, no. 10, pp. 3296–3305, 2004. View at Publisher · View at Google Scholar · View at Scopus
33. G. Citera, M. S. Arriola, J. A. Maldonado-Cocco et al., “Validation and crosscultural adaptation of an Argentine Spanish version of the Health Assessment Questionnaire disability index,” Journal of Clinical Rheumatology, vol. 10, no. 3, pp. 110–115, 2004. View at Publisher · View at Google Scholar · View at Scopus
34. T. M. R. Rojas-LLorena GA, A. Posada-Coello, M. Gilbert-Toledano et al., “Validación de la versión cubana de la dimensión física del Cuestionario de Evaluación de Salud (HAQ) en cubanos con Artritis Reumatoide. (CU-HAQ),” Revista Cubana de Reumatología, vol. 4, pp. 43–55, 2002.
35. T. Pincus, C. J. Swearingen, M. J. Bergman et al., “RAPID3 (Routine Assessment of Patient Index Data) on an MDHAQ (Multidimensional Health Assessment Questionnaire): agreement with DAS28 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) activity categories, scored in five versus more than ninety seconds,” Arthritis Care & Research, vol. 62, no. 2, pp. 181–189, 2010. View at Scopus
36. J. H. Mason, J. J. Anderson, R. F. Meenan, K. M. Haralson, D. Lewis-Stevens, and J. L. Kaine, “The Rapid Assessment of Disease Activity in Rheumatology (RADAR) questionnaire: validity and sensitivity to change of a patient self-report measure of joint count and clinical status,” Arthritis and Rheumatism, vol. 35, no. 2, pp. 156–162, 1992. View at Scopus
37. M. W. Stewart, D. G. Palmer, and R. G. Knight, “A self-report articular index measure of arthritic activity: investigations of reliability, validity and sensitivity,” Journal of Rheumatology, vol. 17, no. 8, pp. 1011–1015, 1990. View at Scopus
38. G. Stucki, S. Stucki, P. Bruhlmann, S. Maus, and B. A. Michel, “Comparison of the validity and reliability of self-reported articular indices,” British Journal of Rheumatology, vol. 34, no. 8, pp. 760–766, 1995. View at Scopus
39. M. L. L. Prevoo, I. H. Kuper, M. A. Van't Hof, M. A. Van Leeuwen, L. B. A. Van De Putte, and P. L. C. M. Van Riel, “Validity and reproducibility of self-administered joint counts. A prospective longitudinal followup study in patients with rheumatoid arthritis,” Journal of Rheumatology, vol. 23, no. 5, pp. 841–845, 1996. View at Scopus
40. F. C. Arnett, S. M. Edworthy, D. A. Bloch et al., “The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis,” Arthritis and Rheumatism, vol. 31, no. 3, pp. 315–324, 1988. View at Scopus
41. T. Pincus, A. M. Oliver, and M. J. Bergman, “How to collect an MDHAQ to provide rheumatology vital signs (function, pain, global status, and RAPID3 scores) in the infrastructure of rheumatology care, including some misconceptions regarding the MDHAQ,” Rheumatic Disease Clinics of North America, vol. 35, no. 4, pp. 799–812, 2009. View at Publisher · View at Google Scholar · View at Scopus
42. T. Pincus, C. J. Swearingen, M. Bergman, and Y. Yazici, “RAPID3 (Routine Assessment of Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to disease activity score and clinical disease activity index categories,” Journal of Rheumatology, vol. 35, no. 11, pp. 2136–2147, 2008. View at Publisher · View at Google Scholar · View at Scopus
43. T. Pincus, Y. Yazici, M. Bergman, C. Swearingen, and T. Harrington, “A proposed approach to recognise "near-remission" quantitatively without formal joint counts or laboratory tests: a patient self-report questionnaire routine assessment of patient index data (RAPID) score as a guide to a "continuous quality improvement" strategy,” Clinical and Experimental Rheumatology, vol. 24, pp. S60–S73, 2006. View at Scopus
44. M. L. L. Prevoo, M. A. Van 'T Hof, H. H. Kuper, M. A. Van Leeuwen, L. B. A. Van De Putte, and P. L. C. M. Van Riel, “Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis,” Arthritis and Rheumatism, vol. 38, no. 1, pp. 44–48, 1995. View at Publisher · View at Google Scholar · View at Scopus
45. J. S. Smolen, F. C. Breedveld, M. H. Schiff et al., “A simplified disease activity index for rheumatoid arthritis for use in clinical practice,” Rheumatology, vol. 42, no. 2, pp. 244–257, 2003. View at Publisher · View at Google Scholar · View at Scopus
46. D. Aletaha and J. Smolen, “The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis,” Clinical and Experimental Rheumatology, vol. 23, pp. S100–S108, 2005. View at Scopus
47. J. Anderson, H. Sayles, J. R. Curtis, F. Wolfe, and K. Michaud, “Converting modified Health Assessment Questionnaire (HAQ), multidimensional HAQ, and HAQII scores into original HAQ scores using models developed with a large cohort of rheumatoid arthritis patients,” Arthritis Care and Research, vol. 62, no. 10, pp. 1481–1488, 2010. View at Publisher · View at Google Scholar · View at Scopus
48. A. Rojas-Villarraga, O. D. Ortega-Hernandez, L. F. Gomez et al., “Risk factors associated with different stages of atherosclerosis in Colombian patients with rheumatoid arthritis,” Seminars in Arthritis and Rheumatism, vol. 38, no. 2, pp. 71–82, 2008. View at Publisher · View at Google Scholar · View at Scopus
49. T. Primero and C. Ii, Ley 30 de Diciembre 28 de 1992, 1992.
50. D. Preliminares, Ley 115 de Febrero 8 de 1994, 1994.
51. A. Rojas-Villarraga, J. Amaya-Amaya, A. Rodriguez-Rodriguez, R. D. Mantilla, and J. M. Anaya, “Introducing polyautoimmunity: secondary autoimmune diseases no longer exist,” Autoimmune Diseases, vol. 2012, Article ID 254319, 9 pages, 2012. View at Publisher · View at Google Scholar
52. G. F. O. R. Referral, M. Of, S. Lupus, and E. In, “Guidelines for referral and management of systemic lupus erythematosus in adults. American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Guidelines,” Arthritis and Rheumatism, vol. 42, pp. 1785–1796, 1999.
53. C. Vitali, S. Bombardieri, R. Jonsson et al., “Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group,” Annals of the Rheumatic Diseases, vol. 61, no. 6, pp. 554–558, 2002. View at Publisher · View at Google Scholar · View at Scopus
54. S. Miyakis, M. D. Lockshin, T. Atsumi et al., “International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS),” Journal of Thrombosis and Haemostasis, vol. 4, no. 2, pp. 295–306, 2006. View at Publisher · View at Google Scholar · View at Scopus
55. A. T. Masi, G. P. Rodnan, and T. A. Medsger, “Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee,” Arthritis and Rheumatism, vol. 23, no. 5, pp. 581–590, 1980. View at Scopus
56. S. Baum, A. Barzilai, and H. Trau, “Vitiligo,” in Diagnostic Criteria in Autoimmune Diseases, Y. Shoenfeld, R. Cervera, and M. E. Gershwin, Eds., pp. 353–358, 2008.
57. J. M. Anaya, G. J. Tobon, P. Vega, and J. Castiblanco, “Autoimmune disease aggregation in families with primary Sjögren's syndrome,” Journal of Rheumatology, vol. 33, no. 11, pp. 2227–2234, 2006. View at Scopus
58. D. Van Der Heijde, “How to read radiographs according to the Sharp/van der Heijde method,” Journal of Rheumatology, vol. 26, no. 3, pp. 743–745, 1999. View at Scopus
59. D. W. Jones and J. E. Hall, “Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure and evidence from new hypertension trials,” Hypertension, vol. 43, no. 1, pp. 1–3, 2004. View at Publisher · View at Google Scholar · View at Scopus
60. D. Wood, “Joint British recommendations on prevention of coronary heart disease in clinical practice: summary,” British Medical Journal, vol. 320, no. 7236, pp. 705–708, 2000. View at Scopus
61. P. Statements, “Standards of medical care in diabetes—2012,” Diabetes Care, vol. 35, supplement 1, pp. S11–S63, 2012.
62. A. L. Catapano, A. L. Reiner, G. De Backer et al., “ESC/EAS Guidelines for the management of dyslipidaemias. The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS),” Atherosclerosis, vol. 217, supplement 1, pp. S1–S44, 2011. View at Publisher · View at Google Scholar · View at Scopus
63. Y. Liao, S. Kwon, S. Shaughnessy et al., “Critical evaluation of adult treatment panel III criteria in identifying insulin resistance with dyslipidemia,” Diabetes Care, vol. 27, no. 4, pp. 978–983, 2004. View at Publisher · View at Google Scholar · View at Scopus
64. S. Klein, D. B. Allison, S. B. Heymsfield et al., “Waist circumference and cardiometabolic risk: a consensus statement from Shaping America's Health: Association for Weight Management and Obesity Prevention; NAASO, the Obesity Society; the American Society for Nutrition; and the American Diabetes Association,” American Journal of Clinical Nutrition, vol. 85, no. 5, pp. 1197–1202, 2007. View at Scopus
65. R. B. D'Agostino, R. S. Vasan, M. J. Pencina et al., “General cardiovascular risk profile for use in primary care: the Framingham heart study,” Circulation, vol. 117, no. 6, pp. 743–753, 2008. View at Publisher · View at Google Scholar · View at Scopus
66. C. Petrie and A. Sabin, “Assessing agreement,” in Medical Statistics at a Glance, pp. 118–119, Wiley-Blackwell, Oxford, UK, 3rd edition, 2010.
67. H. Motulsky, “Correlation,” in Intuitive Biostatistics. A Nonmathematical Guide to Statistical Thinking, pp. 243–251, Oxford University Press, New York, NY, USA, 2nd edition, 2010.
68. T. Pincus and O. G. Segurado, “Most visits of most patients with rheumatoid arthritis to most rheumatologists do not include a formal quantitative joint count,” Annals of the Rheumatic Diseases, vol. 65, no. 6, pp. 820–822, 2006. View at Publisher · View at Google Scholar · View at Scopus
69. T. Pincus, “A multidimensional health assessment questionnaire (MDHAQ) for all patients with rheumatic diseases to complete at all visits in standard clinical care,” Bulletin of the NYU Hospital for Joint Diseases, vol. 65, no. 2, pp. 150–160, 2007. View at Scopus
70. T. Pincus, Y. Yazici, and M. Bergman, “A practical guide to scoring a Multi-Dimensional Health Assessment Questionnaire (MDHAQ) and Routine Assessment of Patient Index Data (RAPID) scores in 10-20 seconds for use in standard clinical care, without rulers, calculators, websites or computers,” Best Practice and Research: Clinical Rheumatology, vol. 21, no. 4, pp. 755–787, 2007. View at Publisher · View at Google Scholar · View at Scopus
71. L. Goodacre, J. Smith, D. Meddis, and J. Goodacre, “Development and validation of a patient-centred Measure of Activity Limitation (MAL) in rheumatoid arthritis,” Rheumatology, vol. 46, no. 4, pp. 703–708, 2007. View at Publisher · View at Google Scholar · View at Scopus
72. D. L. Frosch, R. M. Kaplan, T. G. Ganiats, E. J. Groessl, W. J. Sieber, and M. H. Weisman, “Validity of self-administered quality of well-being scale in musculoskeletal disease,” Arthritis Care and Research, vol. 51, no. 1, pp. 28–33, 2004. View at Scopus
73. B. F. Leeb, P. M. Haindl, A. Maktari, T. Nothnagl, and B. Rintelen, “Patient-centered rheumatoid arthritis disease activity assessment by a modified RADAI,” Journal of Rheumatology, vol. 35, no. 7, pp. 1294–1299, 2008. View at Scopus
74. T. Pincus, T. Sokka, and H. Kautiainen, “Further development of a physical function scale on a Multidimensional Health Assessment Questionnaire for standard care of patients with rheumatic diseases,” Journal of Rheumatology, vol. 32, no. 8, pp. 1432–1439, 2005. View at Scopus
75. T. Pincus and T. Sokka, “Laboratory tests to assess patients with rheumatoid arthritis: advantages and limitations,” Rheumatic Disease Clinics of North America, vol. 35, no. 4, pp. 731–734, 2009. View at Publisher · View at Google Scholar · View at Scopus
76. T. Pincus, C. Swearingen, and F. Wolfe, “Toward a multidimensional Health Assessment Questionnaire (MDHAQ): assessment of advanced activities of daily living and psychological status in the patient-friendly health assessment questionnaire format,” Arthritis and Rheumatism, vol. 42, pp. 2220–2230, 1999.
77. T. Pincus, “Advantages and limitations of quantitative measures to assess rheumatoid arthritis: joint counts, radiographs, laboratory tests, and patient questionnaires,” Bulletin of the NYU Hospital for Joint Diseases, vol. 64, no. 1-2, pp. 32–39, 2006. View at Scopus
78. T. Pincus, R. Maclean, Y. Yazici, and J. T. Harrington, “Quantitative measurement of patient status in the regular care of patients with rheumatic diseases over 25 years as continuous quality improvement activity, rather than traditional research,” Clinical and Experimental Rheumatology, vol. 25, pp. S69–S81, 2007. View at Scopus
79. D. P. Lubeck, “Patient-reported outcomes and their role in the assessment of rheumatoid arthritis,” PharmacoEconomics, vol. 22, no. 2, pp. 27–38, 2004. View at Scopus
80. D. L. Patrick, L. B. Burke, J. H. Powers et al., “Patient-reported outcomes to support medical product labeling claims: FDA perspective,” Value in Health, vol. 10, supplement 2, pp. S125–S137, 2007. View at Publisher · View at Google Scholar · View at Scopus
81. K. Fiscella, S. Ransom, P. Jean-Pierre et al., “Patient-reported outcome measures suitable to assessment of patient navigation,” Cancer, vol. 117, no. 15, pp. 3603–3617, 2011. View at Publisher · View at Google Scholar · View at Scopus
82. K. J. Yost, D. T. Eton, S. F. Garcia, and D. Cella, “Minimally important differences were estimated for six Patient-Reported Outcomes Measurement Information System-Cancer scales in advanced-stage cancer patients,” Journal of Clinical Epidemiology, vol. 64, no. 5, pp. 507–516, 2011. View at Publisher · View at Google Scholar · View at Scopus
83. N. E. Rothrock, R. D. Hays, K. Spritzer, S. E. Yount, W. Riley, and D. Cella, “Relative to the general US population, chronic diseases are associated with poorer health-related quality of life as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS),” Journal of Clinical Epidemiology, vol. 63, no. 11, pp. 1195–1204, 2010. View at Publisher · View at Google Scholar · View at Scopus
84. K. B. Yeatts, B. Stucky, D. Thissen et al., “Construction of the pediatric asthma impact scale (PAIS) for the patient-reported outcomes measurement information system (PROMIS),” Journal of Asthma, vol. 47, no. 3, pp. 295–302, 2010. View at Publisher · View at Google Scholar · View at Scopus
85. M. Brekke, P. Hjortdahl, and T. K. Kvien, “Self-efficacy and health status in rheumatoid arthritis: a two-year longitudinal observational study,” Rheumatology, vol. 40, no. 4, pp. 387–392, 2001. View at Scopus
86. L. Gossec, “Patient-reported outcomes in rheumatoid arthritis: why are they important and how should they be assessed?” Turkish Journal of Rheumatology, vol. 25, no. 3, pp. 99–104, 2010. View at Publisher · View at Google Scholar · View at Scopus
87. Y. Garip, F. Eser, and H. Bodur, “Health-related quality of life in rheumatoid arthritis: comparison of RAQoL with other scales in terms of disease activity, severity of pain, and functional status,” Rheumatology International, vol. 31, no. 6, pp. 769–772, 2011. View at Publisher · View at Google Scholar · View at Scopus
88. T. Pincus, R. H. Brooks, and L. F. Callahan, “Prediction of long-term mortality in patients with rheumatoid arthritis according to simple questionnaire and joint count measures,” Annals of Internal Medicine, vol. 120, no. 1, pp. 26–34, 1994. View at Scopus
89. L. F. Callahan, T. Pincus, J. W. Huston, R. H. Brooks, E. Paul Nance, and J. J. Kaye, “Measures of activity and damage in rheumatoid arthritis: depiction of changes and prediction of mortality over five years,” Arthritis Care and Research, vol. 10, no. 6, pp. 381–394, 1997. View at Scopus
90. T. Sokka, A. Häkkinen, E. Krishnan, and P. Hannonen, “Similar prediction of mortality by the health assessment questionnaire in patients with rheumatoid arthritis and the general population,” Annals of the Rheumatic Diseases, vol. 63, no. 5, pp. 494–497, 2004. View at Publisher · View at Google Scholar · View at Scopus
91. F. Wolfe, K. Michaud, O. Gefeller, and H. K. Choi, “Predicting mortality in patients with rheumatoid arthritis,” Arthritis and Rheumatism, vol. 48, no. 6, pp. 1530–1542, 2003. View at Publisher · View at Google Scholar · View at Scopus
92. T. Pincus, M. J. Bergman, Y. Yazici, P. Hines, K. Raghupathi, and R. Maclean, “An index of only patient-reported outcome measures, routine assessment of patient index data 3 (RAPID3), in two abatacept clinical trials: similar results to disease activity score (DAS28) and other RAPID indices that include physician-reported measures,” Rheumatology, vol. 47, no. 3, pp. 345–349, 2008. View at Publisher · View at Google Scholar · View at Scopus
93. T. Pincus, Y. Yazici, M. Bergman, R. Maclean, and T. Harrington, “A proposed continuous quality improvement approach to assessment and management of patients with rheumatoid arthritis without formal joint counts, based on quantitative routine assessment of patient index data (RAPID) scores on a multidimensional health assessment questionnaire (MDHAQ),” Best Practice and Research: Clinical Rheumatology, vol. 21, no. 4, pp. 789–804, 2007. View at Publisher · View at Google Scholar · View at Scopus
94. A. Blanchais, J. M. Berthelot, A. M. Fontenoy, B. le Goff, and Y. Maugars, “Weekly home self-assessment of RAPID-4/3 scores in rheumatoid arthritis: a 6-month study in 26 patients,” Joint Bone Spine, vol. 77, no. 6, pp. 582–587, 2010. View at Publisher · View at Google Scholar · View at Scopus
95. Y. Yazici, M. Bergman, and T. Pincus, “Time to score quantitative rheumatoid arthritis measures: 28-Joint count, disease activity score, health assessment questionnaire (HAQ), multidimensional HAQ (MDHAQ), and routine assessment of patient index data (RAPID) scores,” Journal of Rheumatology, vol. 35, no. 4, pp. 603–609, 2008. View at Scopus
96. A. Escalante, “What do self-administered joint counts tell us about patients with rheumatoid arthritis?” Arthritis Care and Research, vol. 11, no. 4, pp. 280–290, 1998. View at Scopus
97. D. A. Houssien, G. Stucki, and D. L. Scott, “A patient-derived disease activity score can substitute for a physician-derived disease activity score in clinical research,” Rheumatology, vol. 38, no. 1, pp. 48–52, 1999. View at Publisher · View at Google Scholar · View at Scopus
98. J. Fransen, T. Langenegger, B. A. Michel, and G. Stucki, “Feasibility and validity of the RADAI, a self-administered rheumatoid arthritis disease activity index,” Rheumatology, vol. 39, no. 3, pp. 321–327, 2000. View at Scopus
99. M. Bossert, C. Prati, C. Vidal, S. Bongain, É. Toussirot, and D. Wendling, “Evaluation of self-report questionnaires for assessing rheumatoid arthritis activity: a cross-sectional study of RAPID3 and RADAI5 and flare detection in 200 patients,” Joint Bone Spine, vol. 79, pp. 57–62, 2012. View at Publisher · View at Google Scholar · View at Scopus
100. F. Wolfe, T. Pincus, J. F. Fries, and M. Greenwood, “Usefulness of the HAQ in the clinic,” Annals of the Rheumatic Diseases, vol. 60, no. 8, p. 811, 2001. View at Publisher · View at Google Scholar · View at Scopus
101. J. F. Fries, P. Spitz, R. G. Kraines, and H. R. Holman, “Measurement of patient outcome in arthritis,” Arthritis and Rheumatism, vol. 23, no. 2, pp. 137–145, 1980. View at Scopus
102. F. Salaffi, M. A. Cimmino, G. Leardini, S. Gasparini, and W. Grassi, “Disease activity assessment of rheumatoid arthritis in daily practice: validity, internal consistency, reliability and congruency of the Disease Activity Score including 28 joints (DAS28) compared with the Clinical Disease Activity Index (CDAI),” Clinical and Experimental Rheumatology, vol. 27, no. 4, pp. 552–559, 2009. View at Scopus
103. B. F. Leeb, I. Andel, J. Sautner et al., “Disease activity measurement of rheumatoid arthritis: comparison of the Simplified Disease Activity Index (SDAI) and the Disease Activity Score including 28 joints (DAS28) in daily routine,” Arthritis Care and Research, vol. 53, no. 1, pp. 56–60, 2005. View at Publisher · View at Google Scholar · View at Scopus
104. T. Pincus, Y. Yazici, and M. Bergman, “Development of a multi-dimensional health assessment questionnaire (MDHAQ) for the infrastructure of standard clinical care,” Clinical and Experimental Rheumatology, vol. 23, pp. S19–S28, 2005. View at Scopus
105. B. Rintelen, P. M. Haindl, A. Maktari, T. Nothnagl, E. Hartl, and B. F. Leeb, “SDAI/CDAI levels in rheumatoid arthritis patients are highly dependent on patient's pain perception and gender,” Scandinavian Journal of Rheumatology, vol. 37, no. 6, pp. 410–413, 2008. View at Publisher · View at Google Scholar · View at Scopus
106. T. Pincus, A. D. Askanase, and C. J. Swearingen, “A multi-dimensional health assessment questionnaire (MDHAQ) and routine assessment of patient index data (RAPID3) scores are informative in patients with all rheumatic diseases,” Rheumatic Disease Clinics of North America, vol. 35, no. 4, pp. 819–827, 2009. View at Publisher · View at Google Scholar · View at Scopus
107. G. Levy, C. Cheetham, A. Cheatwood, and R. Burchette, “Validation of patient-reported joint counts in rheumatoid arthritis and the role of training,” Journal of Rheumatology, vol. 34, no. 6, pp. 1261–1265, 2007. View at Scopus
108. C. Werner, “Nivel de conocimiento de los pacientes con artritis reumatoide acerca de su enfermedad y tratamiento,” Revista Medica de Chile, vol. 134, pp. 1500–1506, 2006.
109. J. F. Hogrefe, M. F. Marengo, E. E. Schneerberger, M. Rosemffet, J. C. M. Cocco, and G. Citera, “Valor de corte de HAQ para predecir discapacidad laboral en pacientes con artritis reumatoidea,” Revista Argentina de Reumatología, vol. 20, pp. 23–27, 2009.
110. T. Pincus, Y. Yazici, and T. Sokka, “Quantitative measures of rheumatic diseases for clinical research versus standard clinical care: differences, advantages and limitations,” Best Practice and Research: Clinical Rheumatology, vol. 21, no. 4, pp. 601–628, 2007. View at Publisher · View at Google Scholar · View at Scopus
111. D. Aletaha, R. Landewe, T. Karonitsch et al., “Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations,” Arthritis Care and Research, vol. 59, no. 10, pp. 1371–1377, 2008. View at Publisher · View at Google Scholar · View at Scopus
112. T. Pincus, V. Strand, G. Koch et al., “An index of the three Core Data Set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial,” Arthritis and Rheumatism, vol. 48, no. 3, pp. 625–630, 2003. View at Publisher · View at Google Scholar · View at Scopus
113. T. Pincus, C. Chung, O. G. Segurado, I. Amara, and G. G. Koch, “An index of patient reported outcomes (PRO-Index) discriminates effectively between active and control treatment in 4 clinical trials of adalimumab in rheumatoid arthritis,” Journal of Rheumatology, vol. 33, no. 11, pp. 2146–2152, 2006. View at Scopus
114. F. Wolfe and K. Michaud, “Proposed metrics for the determination of rheumatoid arthritis outcome and treatment success and failure,” Journal of Rheumatology, vol. 36, no. 1, pp. 27–33, 2009. View at Publisher · View at Google Scholar · View at Scopus
115. T. S. Shaver, J. D. Anderson, D. N. Weidensaul et al., “The problem of rheumatoid arthritis disease activity and remission in clinical practice,” Journal of Rheumatology, vol. 35, no. 6, pp. 1015–1022, 2008. View at Scopus
116. T. Pincus, Y. Yazici, and M. J. Bergman, “Beyond rapid3 practical use of the mdhaq to improve doctor-patient communication,” Bulletin of the NYU Hospital for Joint Diseases, vol. 68, no. 3, pp. 223–231, 2010. View at Scopus
117. T. Pincus, J. Keysor, T. Sokka, E. Krishnan, and L. F. Callahan, “Patient questionnaires and formal education level as prospective predictors of mortality over 10 years in 97% of 1416 patients with rheumatoid arthritis from 15 United States private practices,” Journal of Rheumatology, vol. 31, no. 2, pp. 229–234, 2004. View at Scopus
118. P. Studenic, H. Radner, J. S. Smolen, and D. Aletaha, “Discrepancies between patients and physicians in their perceptions of rheumatoid arthritis disease activity,” Arthritis and Rheumatism, vol. 64, no. 9, pp. 2814–2823, 2012. View at Publisher · View at Google Scholar